Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine

The mRNA-1273 SARS-CoV-2 vaccine received emergency use authorization in December 2021. We present a case of myasthenia gravis (MG) which became clinically apparent following vaccination against SARS-CoV-2. A 30-year-old man developed acute onset diplopia, 2 days after receiving his first mRNA-1273...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshina, Yoji, Sowers, Christopher, Baker, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426966/
https://www.ncbi.nlm.nih.gov/pubmed/36051160
http://dx.doi.org/10.12890/2022_003439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426966/
https://www.ncbi.nlm.nih.gov/pubmed/36051160
http://dx.doi.org/10.12890/2022_003439

Ejemplares similares